Join to View Full Profile
3410 Worth StDallas, TX 75246
Phone+1 214-370-1000
Fax+1 214-370-1026
Dr. Nadler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2003 - 2005- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2000 - 2003
Harvard Medical SchoolClass of 2000
Certifications & Licensure
TX State Medical License 2005 - 2025
MA State Medical License 2002 - 2007
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers Start of enrollment: 2010 Jun 01
- Optimal Tube Feeding Method in Head and Neck Cancer Patients Start of enrollment: 2015 Feb 01
- Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy Start of enrollment: 2015 Oct 05
Publications & Presentations
PubMed
- The value of real-world evidence in supporting targeted therapies for patients with rare oncogenic drivers in mNSCLC.Misako Nagasaka, Upal Basu Roy, Alexandra Berk, Geoffrey Liu, Eric Nadler
Future Oncology. 2025-03-14 - Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.Xiuning Le, Eric Nadler, Daniel B Costa, John Victor Heymach
Targeted Oncology. 2024-01-01 - 2 citationsEGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.Xiuning Le, Eric Nadler, Daniel B Costa, John Victor Heymach
Targeted Oncology. 2023-11-01
Press Mentions
US Oncology Research, the US Oncology Network and Ontada Announce Clinical Data Showcased in Plenary and Oral Sessions at ASCO Annual MeetingJune 3rd, 2021
OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung CancerApril 16th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
